Yesterday, I read this story link on One Spot Allergy’s Facebook page, who mentioned that thanks to us, Mylan-the distributors of Epi Pen® have increased their earnings: Mylan rises as allergy injection EpiPen and strong generic-drug sales boost 2nd-qtr results. Yup, Mylan’s earnings from Epi Pen® sales are up, up, up.
Alas, my love hate relationship with Mylan continues. I LOVE the ease of use of the auto-injection system used to deliver life saving epinephrine. Epi Pens® save lives and are critical to any one with life threatening allergies. I HATE that the cost is extraordinarily high and that single packs are no longer available in the United States and many folks can’t afford to buy their prescribed Epi Pens®.
Per Mylan’s press release: “Specialty reported third party net revenues of $360.8 million for the six months ended June 30, 2012, an increase of $132.1 million, or 57.7% over the comparable prior year period amount of $228.7 million. This increase was the result of higher sales of the EPIPEN® auto-injector. ”
Coincidentally, the single packs were phased out during Mylan’s 2011 4th quarter and interestingly enough, their sales have increased since. Hum…in direction relation to the fact that we are forced to buy two packs whether we could afford them or not? I still have not made peace with the fact that access to life threatening epinephrine has become an ordeal. I just don’t know how folk are suppose to afford over $200 for a two pack when purchasing just one auto-injector cost just over $100? I’m having a hard time with the fact that Mylan is enjoying a 57% increase in Epi Pen® sales while I know others, who write to me via this blog, can’t afford one Epi Pen®.
In my post last week, Eureka, I Found the Epi Pen Patient Assistance Program, I noted that I called Mylan twice to learn more about their Patient Assistance program. As of July 12th and July 13th, 2012 , I am still waiting for my return phone call. As you can tell, I am a bit frustrated with Mylan. For some people, the best they afford is a single and buying the two pack is out of their reach thus placing people at risk. Businesses must make profit to stay in business, but where is the line drawn when financial gain outweighs saving a life?
So…Mylan, I hope you are thinking of us and consider coupons, discounts and an Epi Pen® Patient Assistance Customer Service rep who will return calls, in the near future.
[fbshare type=”button”] [pinterest count=”horizontal”]